252 related articles for article (PubMed ID: 30957062)
41. The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients.
Menes TS; Tartter PI; Bleiweiss I; Godbold JH; Estabrook A; Smith SR
Ann Surg Oncol; 2005 Nov; 12(11):881-5. PubMed ID: 16195834
[TBL] [Abstract][Full Text] [Related]
42. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
Morrow M; Van Zee KJ; Solin LJ; Houssami N; Chavez-MacGregor M; Harris JR; Horton J; Hwang S; Johnson PL; Marinovich ML; Schnitt SJ; Wapnir I; Moran MS
J Clin Oncol; 2016 Nov; 34(33):4040-4046. PubMed ID: 27528719
[TBL] [Abstract][Full Text] [Related]
43. Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy.
Kokubo M; Mitsumori M; Yamamoto C; Fujishiro S; Mise K; Kodama H; Nagata Y; Hiraoka M
Breast Cancer; 2001; 8(3):222-8. PubMed ID: 11668244
[TBL] [Abstract][Full Text] [Related]
44. Extreme oncoplasty: breast conservation for patients who need mastectomy.
Silverstein MJ; Savalia N; Khan S; Ryan J
Breast J; 2015; 21(1):52-9. PubMed ID: 25583035
[TBL] [Abstract][Full Text] [Related]
45. Predictors of Residual Disease After Breast Conservation Surgery.
Findlay-Shirras LJ; Outbih O; Muzyka CN; Galloway K; Hebbard PC; Nashed M
Ann Surg Oncol; 2018 Jul; 25(7):1936-1942. PubMed ID: 29748884
[TBL] [Abstract][Full Text] [Related]
46. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
47. Rates of residual disease with close but negative margins in breast cancer surgery.
Garvey EM; Senior DA; Pockaj BA; Wasif N; Dueck AC; McCullough AE; Ocal IT; Gray RJ
Breast; 2015 Aug; 24(4):413-7. PubMed ID: 25845608
[TBL] [Abstract][Full Text] [Related]
48. Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrence.
Vos EL; Gaal J; Verhoef C; Brouwer K; van Deurzen CHM; Koppert LB
Eur J Surg Oncol; 2017 Oct; 43(10):1846-1854. PubMed ID: 28688723
[TBL] [Abstract][Full Text] [Related]
49. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.
Anscher MS; Jones P; Prosnitz LR; Blackstock W; Hebert M; Reddick R; Tucker A; Dodge R; Leight G; Iglehart JD
Ann Surg; 1993 Jul; 218(1):22-8. PubMed ID: 8328825
[TBL] [Abstract][Full Text] [Related]
50. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer.
Solin LJ; Fowble BL; Schultz DJ; Goodman RL
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):279-87. PubMed ID: 1648041
[TBL] [Abstract][Full Text] [Related]
51. Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities.
Perez CA
Cancer J; 2003; 9(6):442-53. PubMed ID: 14740972
[TBL] [Abstract][Full Text] [Related]
52. Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery.
LeeVan E; Ho BT; Seto S; Shen J
Breast Cancer Res Treat; 2020 Aug; 183(1):145-151. PubMed ID: 32607640
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
[TBL] [Abstract][Full Text] [Related]
54. Breast-conserving therapy in breast cancer patients--a 12-year experience.
Mannell A
S Afr J Surg; 2005 May; 43(2):28-30; discussion 30, 32. PubMed ID: 16035379
[TBL] [Abstract][Full Text] [Related]
55. Re-excision rate after sector resection for breast cancer: A 5-year retrospective cohort study.
Clement Z; McLeay W; Hoffmann C; Shin P; Chowdhry M; Eaton M
Breast Dis; 2019; 38(1):7-13. PubMed ID: 30198861
[TBL] [Abstract][Full Text] [Related]
56. No Ink on Ductal Carcinoma
Fregatti P; Gipponi M; Depaoli F; Murelli F; Guenzi M; Bonzano E; Ceppi M; Friedman D
Anticancer Res; 2019 Jan; 39(1):459-466. PubMed ID: 30591495
[TBL] [Abstract][Full Text] [Related]
57. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
[TBL] [Abstract][Full Text] [Related]
58. Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?
Sevinç Aİ; Aksoy SÖ; Güray Durak M; Balcı P
Turk J Med Sci; 2018 Feb; 48(1):28-33. PubMed ID: 29479947
[TBL] [Abstract][Full Text] [Related]
59. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
60. Invasive lobular carcinoma of the breast: should this be regarded as a chronic disease?
Anwar IF; Down SK; Rizvi S; Farooq N; Burger A; Morgan A; Hussien MI
Int J Surg; 2010; 8(5):346-52. PubMed ID: 20420942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
